Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolpidem for Motor and Cognitive Deficits in Late-stage Parkinson's
NCT03621046Phase 2Completed
- Sponsor
- Aston University
- Start
- Aug 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zolpidem in Parkinson's disease (PD), sponsored by Aston University. Started Aug 2018; status: completed.
02
Drugs
zolpidem
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03621046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03621046.